PA
STJ

Perceptive Advisors’s St Jude Medical STJ Stock Holding History

Perceptive Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-233,000
Closed -$18.2M – 230
2016
Q2 		$18.2M Buy
+233,000
New +$16.6M 1.26% 19
2015
Q4 		– Sell
-51,520
Closed -$3.25M – 191
2015
Q3 		$3.25M Buy
+51,520
New +$3.68M 0.26% 66

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Perceptive Advisors's STJ Position: Q3 2016 in Review

Perceptive Advisors sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 233,000 shares — an estimated $18.2M sold.

Perceptive Advisors first reported a position in STJ in Q3 2015 and held it in 2 quarters. The position peaked at $18.2M in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Perceptive Advisors reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Perceptive Advisors sold 233,000 St Jude Medical shares in Q3 2016, an estimated $18.2M.
  • Perceptive Advisors first reported a position in St Jude Medical in Q3 2015 and held it in 2 quarters.
  • Perceptive Advisors's St Jude Medical position peaked at $18.2M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.